Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02326649 · ClinicalTrials.gov registry record
Noninvasive Measurement of CO Using Impedance Cardiography in Patients With CHD
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 21
- Enrollment target
NCT02326649 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 21 participants.
The verdict
NCT02326649 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
This study will test the capability of a non-invasive instrument (the PhysioFlow impedance cardiography instrument) to measure cardiac output in patients with congenital heart disease (CHD). This instrument works by placing electrodes on the skin of a patient and measuring electrical impedance through the chest, which is proportional to blood volume and blood flow at any given time. The instrument has been validated in patients with structurally normal hearts, but in the only two studies using it for patients with CHD, it was deemed too inaccurate for clinical use. The manufacturer of the device would require access to data on the patients in order to improve its accuracy, and that has not been feasible thus far. This study would begin by comparing cardiac output based on the PhysioFlow monitor to standard techniques, then after possible changes to the instrument to enhance accuracy, would test the instrument again in the same way.
Interventions
- DEVICE Physioflow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02326649
The ClinicalTrials.gov registry entry for NCT02326649 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Physioflow is the first listed.
NCT02326649 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02326649 about?
NCT02326649 is a clinical study titled "Noninvasive Measurement of CO Using Impedance Cardiography in Patients With CHD". This study will test the capability of a non-invasive instrument (the PhysioFlow impedance cardiography instrument) to measure cardiac output in patients with congenital heart disease (CHD). This instrument works by placing electrodes on the skin of a patient and measuring electrical impedance throu...
What is the current status of trial NCT02326649?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2014-12. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02326649?
The interventions under investigation include: Physioflow (DEVICE).
Who is sponsoring clinical trial NCT02326649?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.